CF PharmTech scores $65 mln Series D

CF PharmTech Inc, a maker of inhalation products, has raised $65 million in Series D financing. Future Industry Investment Fund was the lead investor.

28 August 2017•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail